We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

35 hedge funds and large institutions have $28.9M invested in Bio-Path Holdings Inc in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 2

105% more capital invested

Capital invested by funds: $14.1M → $28.9M (+$14.8M)

59% more funds holding

Funds holding: 2235 (+13)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

Holders
35
Holders Change
+13
Holders Change %
+59.09%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
5
Reduced
6
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UOTTAIMCU
1
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$9.92M
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.48M +$25.9K +4 +0.9%
Creative Planning
3
Creative Planning
Kansas
$4.2M -$1.41M -218 -35%
HighTower Advisors
4
HighTower Advisors
Illinois
$2.96M -$32.4K -5 -2%
RCA
5
Rowland Carmichael Advisors
Arizona
$1.14M +$712K +110 New
Millennium Management
6
Millennium Management
New York
$1.03M -$104K -16 -14%
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$896K -$6.48K -1 -1%
CWM
8
Concert Wealth Management
California
$775K +$486K +75 New
Goldman Sachs
9
Goldman Sachs
New York
$519K +$6.48K +1 +2%
BFA
10
BlackRock Fund Advisors
California
$508K -$25.9K -4 -8%
UBS Group
11
UBS Group
Switzerland
$315K +$194K +30 New
Renaissance Technologies
12
Renaissance Technologies
New York
$302K +$58.3K +9 +45%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$266K
SCM
14
Segantii Capital Management
Hong Kong
$226K +$149K +23 New
Northern Trust
15
Northern Trust
Illinois
$176K
Deutsche Bank
16
Deutsche Bank
Germany
$135K +$84.2K +13 New
State Street
17
State Street
Massachusetts
$121K +$13K +2 +20%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$104K +$64.8K +10 New
Nomura Holdings
19
Nomura Holdings
Japan
$95K +$58.3K +9 New
Verition Fund Management
20
Verition Fund Management
Connecticut
$90K +$58.3K +9 New
CS
21
Credit Suisse
Switzerland
$89K +$32.4K +5 +125%
VKH
22
Virtu KCG Holdings
New York
$79K +$51.8K +8 New
SG Americas Securities
23
SG Americas Securities
New York
$67K +$38.9K +6 New
BIT
24
BlackRock Institutional Trust
California
$64K
JG
25
Jefferies Group
New York
$64K +$38.9K +6 New

BPTH Hedge Fund Activity: Q1 2016 in Review

35 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2016, worth a combined $28.9M — up 105% from $14.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new BPTH positions and 2 closed out — a net gain of 13 holders — while 5 added to existing stakes and 6 trimmed.

The largest buyer was Concert Wealth Management, opening a new position worth an estimated $486K. The largest seller was Creative Planning, cutting an estimated $1.41M.

  • 35 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2016, up from 22 in Q4 2015.
  • Funds reported $28.9M of Bio-Path Holdings Inc stock for Q1 2016, up 105% quarter-over-quarter.
  • 15 funds opened new Bio-Path Holdings Inc positions in Q1 2016 and 2 closed out, a net change of +13 holders.
  • The largest Bio-Path Holdings Inc buyer in Q1 2016 was Concert Wealth Management, an estimated $486K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2016 was Creative Planning, an estimated $1.41M sold.

Based on aggregated 13F filings for Q1 2016.